Robert Yoder
Corporate Officer/Principal chez TREVENA, INC.
Fortune : 64 981 $ au 30/04/2024
Postes actifs de Robert Yoder
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TREVENA, INC. | Corporate Officer/Principal | 10/12/2018 | - |
| Sales & Marketing | 11/06/2018 | 10/12/2018 |
Historique de carrière de Robert Yoder
Anciens postes connus de Robert Yoder
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| OREXIGEN THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/03/2015 | 01/06/2018 |
Formation de Robert Yoder
| Dickinson College | Undergraduate Degree |
| Emory University | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Corporate Officer/Principal | 1 |
| Sales & Marketing | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TREVENA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
- Bourse
- Insiders
- Robert Yoder
- Expérience
